The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
[mepr-active rule="1" ifallowed="hide"]Anything in-between gets protected[/mepr-active] hey
It’s time for our annual literature update of the best and most discussed articles from 2016! Simply a great discussion on important topics such...
Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...
